News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dendreon Corporation (DNDN) Release: PROVENGE® (sipuleucel-T) Data Presented at an Annual Scientific Urology Meeting



5/7/2013 11:15:41 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE--(BUSINESS WIRE)--May 6, 2013--Dendreon Corporation (NASDAQ: DNDN) today announced the presentation of three PROVENGE® (sipuleucel-T) abstracts from new and ongoing clinical trials at the 2013 American Urological Association (AUA) Annual Meeting from May 4-8, 2013 in San Diego, California.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES